These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21657847)

  • 21. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
    Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J
    Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitro-oxidative stress biomarkers in active and inactive men.
    Bjork L; Jenkins NT; Witkowski S; Hagberg JM
    Int J Sports Med; 2012 Apr; 33(4):279-84. PubMed ID: 22377943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of plasma low-density lipoprotein and oxidized low-density lipoprotein levels with coronary lesion severities in patients with coronary artery disease].
    He XM; Xiang DC; He JX; Hong CJ; Qiu J; Ma J; Zhang JX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):451-6. PubMed ID: 17711689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
    Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N
    Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Mehri S; Attia N; Ben Farhat M; Hammami M
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):515-21. PubMed ID: 20530057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
    Ndrepepa G; Braun S; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
    Clin Chim Acta; 2005 Oct; 360(1-2):178-86. PubMed ID: 15993392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe.
    Grau M; Guxens M; Subirana I; Fitó M; Covas MI; Jacquemin B; Sunyer J; Lanki T; Picciotto S; Bellander T; Katsouyanni K; Schneider A; Peters A; Marrugat J;
    Eur Heart J; 2007 Dec; 28(23):2841-9. PubMed ID: 17947215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients.
    El-Bassiouni EA; Helmy MH; El-Zoghby SM; El-Nabi Kamel MA; Hosny RM
    Br J Biomed Sci; 2007; 64(3):109-16. PubMed ID: 17910279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
    Ogasawara K; Mashiba S; Hashimoto H; Kojima S; Matsuno S; Takeya M; Uchida K; Yajima J
    Clin Chim Acta; 2008 Nov; 397(1-2):42-7. PubMed ID: 18691566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.